Mr Thomas Jeffery Minarik Ii, | |
70475 Ravine St, Abita Springs, LA 70420-3137 | |
(985) 515-0690 | |
Not Available |
Full Name | Mr Thomas Jeffery Minarik Ii |
---|---|
Gender | Male |
Speciality | Case Manager/care Coordinator |
Location | 70475 Ravine St, Abita Springs, Louisiana |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1376309195 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
101YM0800X | Counselor - Mental Health | (* (Not Available)) | Secondary |
171M00000X | Case Manager/care Coordinator | (* (Not Available)) | Primary |
Mailing Address | Practice Location Address |
---|---|
Mr Thomas Jeffery Minarik Ii, 70475 Ravine St, Abita Springs, LA 70420-3137 Ph: (985) 515-0690 | Mr Thomas Jeffery Minarik Ii, 70475 Ravine St, Abita Springs, LA 70420-3137 Ph: (985) 515-0690 |
News Archive
Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has successfully completed its previously announced acquisition of Devicor Medical Products, Inc.
Levels of drug-resistant tuberculosis (TB) in China are nearly twice the global average. Nationwide research published in the open access journal BMC Infectious Diseases has shown that almost 10% of Chinese TB cases are resistant to the most effective first-line drugs.
Ferring Pharmaceuticals announced today a new analysis of data from the Phase 3 ESTHER-1 trial showing that natural variations in anti-Müllerian hormone levels during and between a woman's menstrual cycle have no clinically relevant impact on ovarian response when using AMH to dose Rekovelle for ovarian stimulation.
If your neighborhood is well-lit at night, you may not be sleeping well, according to a study released today that will be presented at the American Academy of Neurology's 68th Annual Meeting in Vancouver, Canada, April 15 to 21, 2016.
A team of scientists led by Oxford University have made a discovery that could improve our chances of developing an effective vaccine against Tuberculosis.
› Verified 4 days ago